John D. Zubkus

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer

David R. Spigel, F. Anthony Greco, John D. Zubkus et al. · Journal of Thoracic Oncology · 2009 · 85 citations · Full text

Phase Ii Trial, Medicine, Pathology +5

Irinotecan (I), carboplatin (C), and radiotherapy (RT) followed by maintenance bevacizumab (B) in the treatment (tx) of limited-stage small cell lung cancer (LS-SCLC): Update of a phase II trial of the Minnie Pearl Cancer Research Network

Jeffrey Patton, David R. Spigel, F. Anthony Greco et al. · Journal of Clinical Oncology · 2006 · 32 citations

Maintenance Bevacizumab, Phase Ii Trial, Medicine +15

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer

Denise A. Yardley, John D. Zubkus, Brooke Daniel et al. · Clinical Breast Cancer · 2010 · 20 citations

Breast Oncology, Oncology, Phase Ii Trial +8

Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer

David R. Spigel, F. Anthony Greco, David Waterhouse et al. · Lung Cancer · 2012 · 16 citations

Oncology, Phase Ii Trial, Immunology +5

Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with limited-stage small cell lung cancer

John D. Zubkus, David R. Spigel, F. Anthony Greco et al. · Journal of Clinical Oncology · 2007 · 15 citations

Pathology, Radiation Medicine, Oncology +16